Gritstone Bio Inc (GRTS)
0.61
+0.03
(+5.19%)
USD |
NASDAQ |
Jul 08, 16:00
0.61
0.00 (0.00%)
After-Hours: 18:38
Gritstone Bio SG&A Expense (Annual): 28.78M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 28.78M |
December 31, 2022 | 28.97M |
December 31, 2021 | 25.93M |
December 31, 2020 | 21.41M |
Date | Value |
---|---|
December 31, 2019 | 19.41M |
December 31, 2018 | 11.81M |
December 31, 2017 | 6.072M |
December 31, 2016 | 5.064M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
19.41M
Minimum
2019
28.97M
Maximum
2022
24.90M
Average
25.93M
Median
2021
SG&A Expense (Annual) Benchmarks
Marinus Pharmaceuticals Inc | 61.15M |
Petros Pharmaceuticals Inc | 9.262M |
NovaBay Pharmaceuticals Inc | 12.83M |
Palatin Technologies Inc | 15.29M |
iBio Inc | 19.02M |